UK and Switzerland Seal Services-Focused Free Trade Deal

On 13 July 2026, the United Kingdom and Switzerland announced a services-only free trade agreement accompanied by a separate travel pact. The agreement is projected to unlock £5.2 billion ($6.96 billion) a year in additional UK exports to Switzerland and will introduce e-gate access for British travelers at Swiss airports, beginning with Zurich later in the year and expanding to Basel and Geneva the following year. Data-roaming charges for visitors will be eliminated, and UK-based services professionals will enjoy visa-free stays of up to 90 days for business trips.

The Guardian

The pact marks the sixth trade deal the UK has concluded in two years, part of a broader post-Brexit strategy to deepen economic ties with Europe despite Switzerland not being an EU member. Services account for 81 % of UK GDP and 83 % of employment, making the sector the country’s “super-power.” Switzerland is the UK’s sixth-largest services market, valued at roughly £30 billion annually, especially in finance and life sciences.

Why Is The UK's Switzerland Trade Deal Significant

The UK government called the accord the “most significant trade agreement for services” ever signed by Britain, emphasizing its role in “making life easier and creating more opportunity” for UK businesses. Trade policy minister Chris Bryant highlighted cooperation in financial services, insurance and life sciences, and framed the deal as evidence of Britain’s intent to pursue closer European trade links while keeping open the possibility of future EU re-integration. Swiss officials reiterated commitment to existing pharmaceutical patent protections and praised the reduction of border friction for business travelers.

Why Is The UK's Switzerland Trade Deal Significant

The CBI chief executive Rain Newton-Smith said the deal recognises “real opportunities for growth” in services, reinforcing the sector’s status as the UK’s economic “super power.” Pharmaceutical leaders, including Richard Torbett of the Association of the British Pharmaceutical Industry and Mark Samuels of Medicines UK, welcomed the maintenance of current intellectual-property terms, noting that earlier reports of a UK push to shorten patent lengths had not materialised. Their statements underscore industry confidence that the agreement will safeguard NHS access to affordable generics while preserving a “strong and proportionate” IP regime.

The Guardian

• “government described the deal as the "most significant trade agreement for services" ever concluded by the country.” — UK government statement

CNBC

• “Whether you’re growing a business or travelling for work, this agreement is about making life easier and creating more opportunity for people across the UK.” — Keir Starmer, Prime Minister

The Guardian

• “gold standard” — Chris Hayward, City of London Corporation policy chair

The Guardian

• “made explicit their commitment to maintain a strong and proportionate intellectual property regime” — Richard Torbett, chief executive, Association of the British Pharmaceutical Industry

The Guardian